SCHEMBL6962218

SCHEMBL6962218

COc1cc(C(=O)N2CCO[C@](CCO)(c3ccc(Cl)c(Cl)c3)C2)cc(OC)c1OC.CS(=O)(=O)O

nearest known ligand 0.60

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TACR1 known ✓ P25103 3/20 0.48
TACR2 P21452 3/20 0.48
TACR3 P29371 1/20 0.48
HRH1 P35367 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7494913 1.00 TACR2 (0.48) TACR2TACR1TACR3HRH1
SCHEMBL3979392 0.96 TACR2 (0.51) TACR2TACR1TACR3HRH1
SCHEMBL3979384 0.96 TACR2 (0.51) TACR2TACR1TACR3HRH1
SCHEMBL7497843 0.95 TACR2 (0.47) TACR2TACR1TACR3HRH1
SCHEMBL7499048 0.95 TACR2 (0.47) TACR2TACR1TACR3HRH1
SCHEMBL7498650 0.91 TACR2 (0.50) TACR2TACR1TACR3HRH1
SCHEMBL27479835 0.91 TACR2 (0.50) TACR2TACR1TACR3HRH1
SCHEMBL27479834 0.91 TACR2 (0.50) TACR2TACR1TACR3HRH1
SCHEMBL6962224 0.90 TACR2 (0.48) TACR2TACR1TACR3HRH1
SCHEMBL7494916 0.90 TACR2 (0.48) TACR2TACR1TACR3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1057827-B1 SPIROPIPERIDINE DERIVATIVES SANKYO CO (JP) 2003-09-10 EP disclosed
EP-0987269-B1 SALTS OF OPTICALLY ACTIVE SULFOXIDE DERIVATIVE SANKYO CO (JP) 2003-08-13 EP disclosed
US-6511975-B1 Exhibit antagonistic action against tachykinin receptors SANKYO COMPANY, LIMITED (JP) 2003-01-28 US disclosed
US-6448247-B1 TACHYKININ RECEPTOR ANTAGONIST; ESPECIALLY TO THE RECEPTORS FOR SUBSTANCE P (WHICH RECEPTORS ARE GENERALLY REFERRED TO AS ?NEUROKININ 1 RECEPTORS?) SANKYO COMPANY, LIMITED (JP) 2002-09-10 US disclosed
US-6362179-B1 PSYCHOLOGICAL DISORDERS; NERVOUS SYSTEM DISORDERS SANKYO COMPANY, LIMITED (JP) 2002-03-26 US disclosed
EP-0776893-B1 Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 SANKYO CO (JP) 2002-02-27 EP disclosed
US-6159967-A Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use SANKYO COMPANY, LIMITED (JP) 2000-12-12 US disclosed
EP-1057827-A1 SPIROPIPERIDINE DERIVATIVES Sankyo Company Limited (JP) 2000-12-06 EP disclosed
EP-0987269-A1 SALTS OF OPTICALLY ACTIVE SULFOXIDE DERIVATIVE Sankyo Company Limited (JP) 2000-03-22 EP disclosed
CN-1157286-A N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide SANKYO CO (JP) 1997-08-20 CN disclosed
EP-0776893-A1 Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 SANKYO COMPANY LIMITED (JP) 1997-06-04 EP disclosed